FRONTEO Healthcare’s new AI (artificial intelligence) is built upon the healthcare industry’s most fundamental requirement—evidence-based medicine. Through our data analysis capability, we hope to support people around the world in receiving the best healthcare services and pave the way to a healthier, more secure future.
Press ReleaseMay 22, 2018
Press ReleaseMay 16, 2018
NewsFeb 27, 2018FRONTEO Healthcare website is updated.
NewsFeb 14, 2018
Press ReleaseMay 8, 2017
Our AI-based technology reads written entries from examination records and brings a new objectivity to the evaluation of new drugs. By combining this technology with conventional quantitative/structured data analysis, it is possible to make the evaluation of pharmaceuticals even more precise. Using our sophisticated AI technology, we will find new value in pharmaceuticals, as well as support all healthcare workers.
Healthcare Operational Support
Case: An AI-based system to mitigate patients’ risk of falling
FRONTEO Healthcare's AI can be used to analyze hospital incident reports, including data on patient conditions from electronic folders as well as the text data of free comments found in daily records of examination and treatment. This allows the AI to calculate the risk of falls faced by the hospital's patients. Based on projections regarding accidents involving falls and a variety of other potential risks internal to healthcare institutions, we are able to detect symptoms that are signs of adverse events—a task that was previously left to the experience and intuition of nurses in the workplace—from electronic medical records in an accurate, rapid, and continuous fashion. In this way, FRONTEO Healthcare's AI can identify those patients who are at a high risk of falling and thus especially in need of nursing care, contribute to reducing unexpected adverse events, and provide reliable support for the work of medical staff.
Introducing a system for appropriately evaluating and sharing the collective expertise of healthcare workers will create better hospital environments, and increasing the time of interaction between nurses and patients will facilitate greater focus, as should be the case, on the care of each patient.
Pharmaceutical Industry Support
With the globalization of the pharmaceutical industry, pharmacovigilance continues to grow in importance. While accurate and prompt responses are required for pharmacovigilance, the processing of text data, which includes reports filed in a variety of formats, has proved time-consuming in practice, and there have been many instances where important elements were overlooked. FRONTEO Healthcare's AI enables the resolution of such issues faced in clinical practice through the analysis of text data. With the aim of making pharmacovigilance work significantly more efficient and of higher quality, we will contribute toward the management of safety information for pharmaceuticals.
|Company name||FRONTEO Healthcare, Inc.|
|Date of foundation||April 16, 2015|
|Capital amount||JPY 327,000 thousand (On the date of February 1, 2017)|
|Location||Meisan Takahama building, 2-12-23, Konan, Minato-ku, Tokyo 108-0075
Please refer to the contact form below.